皮肤科医生筛查银屑病关节炎:PURE-4量表的开发与首次验证
在法国圣约瑟夫医院连续纳入2012至2014年确诊的银屑病患者,由皮肤科医生协助完成问卷、风湿科医生按CASPAR标准诊断银屑病关节炎(PsA),通过多变量逻辑回归构建4条目PURE-4量表(0-4分),内部验证显示阈值≥1/4分时AUC为87.6%、敏感性85.7%、特异性83.6%。
要点
- PURE-4量表含4个独立条目:指趾炎提示征、炎性足跟痛、双侧臀部痛、年龄<50岁伴外周关节肿胀痛。
- 阈值≥1/4分时AUC=87.6%,敏感性85.7%,特异性83.6%。
- 作者认为若在其他人群中被证实,该量表可能有助于门诊皮肤科分诊需风湿科进一步评估的银屑病患者。
核心结论
- PURE-4量表仅用4个易于采集的条目即显示出良好的诊断性能,若在其他人群中被证实,可能有助于门诊皮肤科分诊需风湿科进一步评估的银屑病患者。
研究设计与样本
- 在法国巴黎圣约瑟夫医院连续招募2012至2014年间医学诊断的银屑病患者,由皮肤科医生协助完成问卷,风湿科医生依据CASPAR标准诊断PsA。
- 文献回顾后选出23个条目,涵盖不同部位疼痛及PsA炎症体征,采用多变量逻辑回归构建量表,以敏感性、特异性和ROC曲线下面积(AUC)评估区分度,最终模型用bootstrapping技术进行内部验证。
主要发现
- 共招募168例患者,排除已知PsA的9例和未参加风湿科会诊的21例,纳入137例(中位年龄43岁,59.6%为男性),其中21例(15.3%)诊断为PsA。
- 最终回归模型保留4个独立条目:指趾炎提示征、炎性足跟痛、双侧臀部痛、年龄<50岁患者的外周关节疼痛伴肿胀。
- PURE-4总评分(0-4分)在阈值≥1/4分时AUC=87.6%,敏感性=85.7%,特异性=83.6%,bootstrapped内部验证未显示过度乐观的证据。
关键数值与推荐
- PURE-4量表评分范围0-4分,阈值≥1/4分时AUC=87.6%,敏感性=85.7%,特异性=83.6%。
- PsA诊断由风湿科医生依据CASPAR标准确立。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dermatologists are recommended to ask psoriasis patients about musculoskeletal complaints to allow early detection and treatment of psoriatic arthritis (PsA). Screening tools have been developed to help identify patients warranting further rheumatologic assessment, but evidence suggests room for improvement in their diagnostic value and ease of use for outpatient practice. OBJECTIVE: To develop and internally validate a brief tool for dermatologists to screen patients to refer to a rheumatologist for PsA diagnosis. METHODS: After the literature review, 23 items were selected, covering pain at various locations and inflammatory signs of PsA. The validation study was conducted in medically diagnosed psoriasis patients consecutively recruited between 2012 and 2014 (Saint Joseph Hospital, Paris, France). Patients were enrolled by a dermatologist who helped to complete the questionnaire. Diagnosis of PsA was established by a rheumatologist based on CASPAR criteria. Multivariate logistic regression models were performed to build the scale, assessing discrimination through sensitivity, specificity and area under the ROC curve (AUC). Final model was internally validated using bootstrapping techniques. RESULTS: One hundred and sixty-eight patients were recruited, of whom nine were excluded for known PsA and 21 did not attend the rheumatologist consultation. Of 137 included patients (median age 43 years, 59.6% men), 21 (15.3%) had a PsA diagnosis. Final regression model retained four independent items, including evocative signs of dactylitis, inflammatory heel pain, bilateral buttock pain and peripheral joint pain with swelling in patients aged <50. A total score (the PURE-4) was computed (0-4 points) that demonstrated excellent discriminative power (AUC = 87.6%; Sensitivity = 85.7% and Specificity = 83.6% at the threshold of ≥1/4 points), with no evidence for over-optimism in bootstrapped internal validation. CONCLUSION: These findings demonstrate the good diagnostic properties of a new screening scale using only four easy-to-collect items. If confirmed in other populations, it may prove useful in outpatient dermatology clinics for triage of psoriasis patients requiring further assessment by the rheumatologist.
引用
- Audureau E, Roux F, Lons Danic D, et al. Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'. J Eur Acad Dermatol Venereol. 2018. PMID: 29430720. doi:10.1111/jdv.14861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。